5,758
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons

, , , , , , , , , & show all
Pages 1020-1048 | Received 27 Oct 2020, Accepted 03 Aug 2021, Published online: 06 Oct 2021

References

  • Galloway DA, Phillips AEM, Owen DRJ, et al. Phagocytosis in the Brain: homeostasis and Disease. Front Immunol. 2019;10:790.
  • Hernandez DG, Reed X, Singleton AB. Genetics in Parkinson disease: mendelian versus non-Mendelian inheritance. J Neurochem. 2016 Oct;139(Suppl 1):59–74.
  • Visanji NP, Brotchie JM, Kalia LV, et al. alpha-Synuclein-Based animal models of Parkinson’s Disease: challenges and opportunities in a New Era. Trends Neurosci. 2016 Nov;39(11):750–762.
  • Lee SJ, Desplats P, Lee HJ, et al. Cell-to-cell transmission of alpha-synuclein aggregates. Methods Mol Biol. 2012;849:347–359.
  • Danzer KM, Kranich LR, Ruf WP, et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener. 2012 Aug 24;7(1):42.
  • Freeman D, Cedillos R, Choyke S, et al. Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis. PLoS One. 2013;8(4):e62143.
  • Hansen C, Angot E, Bergstrom AL, et al. alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest. 2011 Feb 1;121(2):715–725.
  • Luk KC, Kehm VM, Zhang B, et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med. 2012 May 7;209(5):975–986.
  • Peelaerts W, Bousset L, Van der Perren A, et al. alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015 Jun 18;522(7556):340–344.
  • Rey NL, Steiner JA, Maroof N, et al. Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease. J Exp Med. 2016 Aug 22;213(9):1759–1778.
  • Desplats P, Lee HJ, Bae EJ, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010–13015.
  • Kordower JH, Chu Y, Hauser RA, et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med. 2008 May;14(5):504–506.
  • Kordower JH, Chu Y, Hauser RA, et al. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord. 2008 Dec 15;23(16):2303–2306.
  • Li JY, Englund E, Widner H, et al. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson’s disease. Mov Disord. 2010 Jun 15;25(8):1091–1096.
  • Luk KC, Song C, O’Brien P, et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20051–20056.
  • Luk KC, Kehm V, Carroll J, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012 Nov 16;338(6109):949–953.
  • Frake RA, Ricketts T, Menzies FM, et al. Autophagy and neurodegeneration. J Clin Invest. 2015 Jan;125(1):65–74.
  • Weidberg H, Shvets E, Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem. 2011;80:125–156.
  • Cuervo AM, Stefanis L, Fredenburg R, et al. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004 Aug 27;305(5688):1292–1295.
  • Tofaris GK. Lysosome-dependent pathways as a unifying theme in Parkinson’s disease. Mov Disord. 2012 Sep 15;27(11):1364–1369.
  • Tofaris GK, Kim HT, Hourez R, et al. Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway. Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17004–17009.
  • Johannes L, Jacob R, Leffler H. Galectins at a glance. J Cell Sci. 2018 May 1;131(9). DOI:https://doi.org/10.1242/jcs.208884.
  • Tan Y, Zheng Y, Xu D, et al. Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer’s disease. Cell Biosci. 2021 Apr 27;11(1):78.
  • Paz I, Sachse M, Dupont N, et al. Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol. 2010 Apr 1;12(4):530–544.
  • Thurston TL, Wandel MP, von Muhlinen N, et al. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature. 2012 Feb 16;482(7385):414–418.
  • Randow F, MacMicking JD, James LC. Cellular self-defense: how cell-autonomous immunity protects against pathogens. Science. 2013 May 10;340(6133):701–706.
  • Randow F, Youle RJ. Self and nonself: how autophagy targets mitochondria and bacteria. Cell Host Microbe. 2014 Apr 09;15(4):403–411.
  • Flavin WP, Bousset L, Green ZC, et al. Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins. Acta Neuropathol. 2017 Oct;134(4):629–653.
  • Bussi C, Peralta Ramos JM, Arroyo DS, et al. Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells. J Cell Sci. 2018 Nov 30;131(23).
  • Falcon B, Noad J, McMahon H, et al. Galectin-8-mediated selective autophagy protects against seeded tau aggregation. J Biol Chem. 2018 Feb 16;293(7):2438–2451.
  • Ashraf GM, Baeesa SS. Investigation of Gal-3 expression pattern in serum and cerebrospinal fluid of patients suffering from neurodegenerative disorders. Front Neurosci. 2018;12:430.
  • Rousseaux MWC, Vazquez-Velez GE, Al-Ramahi I, et al. A druggable genome screen identifies modifiers of alpha-synuclein levels via a tiered cross-species validation approach. J Neurosci. 2018 Oct 24;38(43):9286–9301.
  • Rusmini P, Cortese K, Crippa V, et al. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy. 2019 Apr;15(4):631–651.
  • Diogo D, Tian C, Franklin CS, et al. Phenome-wide association studies across large population cohorts support drug target validation. Nat Commun. 2018 Oct 16;9(1):4285.
  • Billingsley KJ, Barbosa IA, Bandres-Ciga S, et al. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset. NPJ Parkinsons Dis. 2019;5:8.
  • Chauhan S, Kumar S, Jain A, et al. TRIMs and galectins globally cooperate and TRIM16 and galectin-3 Co-direct autophagy in endomembrane damage homeostasis. Dev Cell. 2016 Oct 10;39(1):13–27.
  • Jia J, Abudu YP, Claude-Taupin A, et al. Galectins control mTOR in response to endomembrane damage. Mol Cell. 2018 Apr 5;70(1):120–135 e8.
  • Jia J, Claude-Taupin A, Gu Y, et al. Galectin-3 coordinates a cellular system for lysosomal repair and removal. Dev Cell. 2020 Jan 6;52(1):69–87 e8.
  • Kimura T, Jia J, Kumar S, et al. Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J. 2017 Jan 04;36(1):42–60.
  • Kumar S, Chauhan S, Jain A, et al. Galectins and TRIMs directly interact and orchestrate autophagic response to endomembrane damage. Autophagy. 2017 Jun 3;13(6):1086–1087.
  • Wang X, Zhang S, Lin F, et al. Elevated Galectin-3 levels in the serum of patients with Alzheimer’s Disease. Am J Alzheimers Dis Other Demen. 2015 Dec;30(8):729–732.
  • Dupont N, Jiang S, Pilli M, et al. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J. 2011 Nov 08;30(23):4701–4711.
  • Ponpuak M, Mandell MA, Kimura T, et al. Secretory autophagy. Curr Opin Cell Biol. 2015 Aug;35:106–116.
  • Christensen DP, Ejlerskov P, Rasmussen I, et al. Reciprocal signals between microglia and neurons regulate alpha-synuclein secretion by exophagy through a neuronal cJUN-N-terminal kinase-signaling axis. J Neuroinflammation. 2016 Mar 08;13(1):59.
  • Poehler AM, Xiang W, Spitzer P, et al. Autophagy modulates SNCA/alpha-synuclein release, thereby generating a hostile microenvironment. Autophagy. 2014;10(12):2171–2192.
  • Alvarez-Erviti L, Seow Y, Schapira AH, et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis. 2011 Jun;42(3):360–367.
  • Minakaki G, Menges S, Kittel A, et al. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018;14(1):98–119.
  • Lee HJ, Cho ED, Lee KW, et al. Autophagic failure promotes the exocytosis and intercellular transfer of alpha-synuclein. Exp Mol Med. 2013;45:e22.
  • Hasegawa T, Konno M, Baba T, et al. The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of alpha-synuclein. PLoS One. 2011;6(12):e29460.
  • Fussi N, Hollerhage M, Chakroun T, et al. Exosomal secretion of alpha-synuclein as protective mechanism after upstream blockage of macroautophagy. Cell Death Dis. 2018 Jul 9;9(7):757.
  • Gudbergsson JM, Johnsen KB. Exosomes and autophagy: rekindling the vesicular waste hypothesis. J Cell Commun Signal. 2019 Dec;13(4):443–450.
  • Jang A, Lee HJ, Suk JE, et al. Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions. J Neurochem. 2010 Jun;113(5):1263–1274.
  • Borland H, Vilhardt F. Prelysosomal compartments in the unconventional secretion of amyloidogenic seeds. Int J Mol Sci. 2017 Jan 23;18(1):227.
  • Ejlerskov P, Rasmussen I, Nielsen TT, et al. Tubulin polymerization-promoting protein (TPPP/p25alpha) promotes unconventional secretion of alpha-synuclein through exophagy by impairing autophagosome-lysosome fusion. J Biol Chem. 2013 Jun 14;288(24):17313–17335.
  • Cai W, Feng D, Schwarzschild MA, et al. Bimolecular fluorescence complementation of alpha-synuclein demonstrates its oligomerization with dopaminergic phenotype in mice. EBioMedicine. 2018 Mar;29:13–22.
  • Outeiro TF, Putcha P, Tetzlaff JE, et al. Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One. 2008 Apr 2;3(4):e1867.
  • Kiechle M, von Einem B, Hofs L, et al. In vivo protein complementation demonstrates presynaptic alpha-synuclein oligomerization and age-dependent accumulation of 8-16-mer oligomer species. Cell Rep. 2019 Nov 26;29(9):2862–2874 e9.
  • Eckermann K, Kugler S, Bahr M. Dimerization propensities of Synucleins are not predictive for Synuclein aggregation. Biochim Biophys Acta. 2015 Aug;1852(8):1658–1664.
  • Holmqvist S, Chutna O, Bousset L, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014 Dec;128(6):805–820.
  • Aelvoet SA, Ibrahimi A, Macchi F, et al. Noninvasive bioluminescence imaging of alpha-synuclein oligomerization in mouse brain using split firefly luciferase reporters. J Neurosci. 2014 Dec 03;34(49):16518–16532.
  • Danzer KM, Ruf WP, Putcha P, et al. Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 2011 Jan;25(1):326–336.
  • Kondo N, Miyauchi K, Meng F, et al. Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain. J Biol Chem. 2010 May 7;285(19):14681–14688.
  • Bousset L, Pieri L, Ruiz-Arlandis G, et al. Structural and functional characterization of two alpha-synuclein strains. Nat Commun. 2013;4:2575.
  • Mauvezin C, Nagy P, Juhasz G, et al. Autophagosome-lysosome fusion is independent of V-ATPase-mediated acidification. Nat Commun. 2015 May;11(6):7007.
  • Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11(8):1437–1438.
  • Yamamoto A, Tagawa Y, Yoshimori T, et al. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct. 1998 Feb;23(1):33–42.
  • Fernandes HJ, Hartfield EM, Christian HC, et al. ER Stress and autophagic perturbations lead to elevated extracellular alpha-synuclein in GBA-N370S Parkinson’s iPSC-derived dopamine neurons. Stem Cell Reports. 2016 Mar 8;6(3):342–356.
  • Kunadt M, Eckermann K, Stuendl A, et al. Extracellular vesicle sorting of alpha-Synuclein is regulated by sumoylation. Acta Neuropathol. 2015 May;129(5):695–713.
  • Banfer S, Jacob R. Galectins in intra- and extracellular vesicles. Biomolecules. 2020 Aug 24;10(9):1232.
  • Ohman T, Teirila L, Lahesmaa-Korpinen AM, et al. Dectin-1 pathway activates robust autophagy-dependent unconventional protein secretion in human macrophages. J Immunol. 2014 Jun 15;192(12):5952–5962.
  • Grey M, Dunning CJ, Gaspar R, et al. Acceleration of alpha-synuclein aggregation by exosomes. J Biol Chem. 2015 Jan 30;290(5):2969–2982.
  • Catalano M, O’Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles. 2020;9(1):1703244.
  • Leidal AM, Huang HH, Marsh T, et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol. 2020 Feb;22(2):187–199.
  • Back MJ, Ha HC, Fu Z, et al. Activation of neutral sphingomyelinase 2 by starvation induces cell-protective autophagy via an increase in Golgi-localized ceramide. Cell Death Dis. 2018 Jun 4;9(6):670.
  • Burbidge K, Zwikelmaier V, Cook B, et al. Cargo and cell-specific differences in extracellular vesicle populations identified by multiplexed immunofluorescent analysis. J Extracell Vesicles. 2020;9(1):1789326.
  • O’Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol. 2000 Nov;74(21):10074–10080.
  • Sandhof CA, Hoppe SO, Druffel-Augustin S, et al. Reducing INS-IGF1 signaling protects against non-cell autonomous vesicle rupture caused by SNCA spreading. Autophagy. 2020 May;16(5):878–899.
  • Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019 Jul 15;8(7):727.
  • Stewart SE, Menzies SA, Popa SJ, et al. A genome-wide CRISPR screen reconciles the role of N-linked glycosylation in galectin-3 transport to the cell surface. J Cell Sci. 2017 Oct 1;130(19):3234–3247.
  • Skowyra ML, Schlesinger PH, Naismith TV, et al. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science. 2018 Apr 6;360(6384):eaar5078.
  • Frahm S, Melis V, Horsley D, et al. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson’s disease. Behav Brain Res. 2018 Feb 26;339:153–168.
  • Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci. 2017 Aug 28;18(9):1865.
  • Jena KK, Kolapalli SP, Mehto S, et al. TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy. EMBO J. 2018 Sep 14;37(18). DOI:https://doi.org/10.15252/embj.201798358.
  • Echevarria J, Royo F, Pazos R, et al. Microarray-based identification of lectins for the purification of human urinary extracellular vesicles directly from urine samples. Chembiochem. 2014 Jul 21;15(11):1621–1626.
  • Jia J, Abudu YP, Claude-Taupin A, et al. Galectins control MTOR and AMPK in response to lysosomal damage to induce autophagy. Autophagy. 2019 Jan;15(1):169–171.
  • Chen WT, Zhang F, Zhao XQ, et al. Galectin-3 and TRIM16 coregulate osteogenic differentiation of human bone marrow-derived mesenchymal stem cells at least partly via enhancing autophagy. Bone. 2020 Feb;131:115059.
  • Cohen MJ, Chirico WJ, Lipke PN. Through the back door: unconventional protein secretion. The Cell Surface. 2020;6:100045.
  • Salimi L, Akbari A, Jabbari N, et al. Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells. Cell Biosci. 2020 May 13;10(1):64.
  • Chen Y-D, Fang Y-T, Cheng Y-L, et al. Exophagy of annexin A2 via RAB11, RAB8A and RAB27A in IFN-γ-stimulated lung epithelial cells. Sci Rep. 2017 Jul 18;7(1):5676.
  • Hurwitz SN, Cheerathodi MR, Nkosi D, et al. Tetraspanin CD63 bridges autophagic and endosomal processes to regulate exosomal secretion and intracellular signaling of Epstein-Barr Virus LMP1. J Virol. 2018;92(5):e01969–17.
  • Jiang P, Gan M, Yen SH, et al. Impaired endo-lysosomal membrane integrity accelerates the seeding progression of alpha-synuclein aggregates. Sci Rep. 2017 Aug 9;7(1):7690.
  • Hoffmann AC, Minakaki G, Menges S, et al. Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose. Sci Rep. 2019 Jan 24;9(1):544.
  • Hou X, Watzlawik JO, Fiesel FC, et al. Autophagy in Parkinson's Disease. J Mol Biol. 2020 Apr 3;432(8):2651–2672
  • Stefanis L, Emmanouilidou E, Pantazopoulou M, et al. How is alpha-synuclein cleared from the cell? J Neurochem. 2019;150(5):577–590.
  • Yu WH, Dorado B, Figueroa HY, et al. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am J Pathol. 2009 Aug;175(2):736–747.
  • Flavin WP, Bousset L, Green ZC, et al. Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins. Acta Neuropathol. 2017 May 19;134(4):629–653.
  • Uversky VN, Li J, Fink AL. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J Biol Chem. 2001 Apr 6;276(14):10737–10744.
  • Hoyer W, Antony T, Cherny D, et al. Dependence of alpha-synuclein aggregate morphology on solution conditions. J Mol Biol. 2002 Sep 13;322(2):383–393.
  • Fraiberg M, Elazar Z. A TRIM16-Galactin3 complex mediates autophagy of damaged endomembranes. Dev Cell. 2016 Oct 10;39(1):1–2.
  • Nilsson E, Ghassemifar R, Brunk UT. Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress. Histochem J. 1997 Nov-Dec;29(11–12):857–865.
  • Johansson AC, Appelqvist H, Nilsson C, et al. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis. 2010 May;15(5):527–540.
  • Meiser J, Weindl D, Hiller K. Complexity of dopamine metabolism. Cell Commun Signaling. 2013 May 17;11(1):34.
  • Seibler P, Graziotto J, Jeong H, et al. Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci. 2011 Apr 20;31(16):5970–5976.
  • Mazzulli JR, Zunke F, Isacson O, et al. alpha-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models. Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1931–1936.
  • Mazzulli JR, Xu YH, Sun Y, et al. Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell. 2011 Jul 08;146(1):37–52.
  • Cooper O, Seo H, Andrabi S, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease. Sci Transl Med. 2012 Jul 4;4(141):141ra90.
  • Pitcairn C, Wani WY, Mazzulli JR. Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson’s disease. Neurobiol Dis. 2019 Feb;122:72–82.
  • Kriks S, Shim JW, Piao J, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature. 2011 Nov 06;480(7378):547–551.
  • Perrier AL, Tabar V, Barberi T, et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12543–12548.
  • Zhang Y, Meredith GE, Mendoza-Elias N, et al. Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses. J Neurosci. 2013 Jul 10;33(28):11655–11667.
  • Rademacher DJ, Mendoza-Elias N, Meredith GE. Effects of context-drug learning on synaptic connectivity in the basolateral nucleus of the amygdala in rats. Eur J Neurosci. 2015 Jan;41(2):205–215.
  • Peters A, Palay SL, Webster H. Neurons and their supporting cells. New York: Oxford University Press; 1991. (The Fine Structure of the Nervous System:).
  • Kung L, Force M, Chute DJ, et al. Immunocytochemical localization of tyrosine hydroxylase in the human striatum: a postmortem ultrastructural study. J Comp Neurol. 1998;390(1):52–62.
  • Menon V, Thomas R, Ghale AR, et al. Flow cytometry protocols for surface and intracellular antigen analyses of neural cell types. J Vis Exp. 2014 Dec;18(94):52241.
  • Ghee M, Melki R, Michot N, et al. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly. FEBS J. 2005 Aug;272(16):4023–4033.
  • Rey NL, Bousset L, George S, et al. alpha-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb. Acta Neuropathol Commun. 2019 Dec 30;7(1):221.
  • Kaja S, Payne AJ, Naumchuk Y, et al. Quantification of lactate dehydrogenase for cell viability testing using cell lines and primary cultured astrocytes. Curr Protoc Toxicol. 2017 May 2;72:2 26 1–2 26 10.
  • Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014 Aug;11(8):783–784.
  • Dhillon JS, Riffe C, Moore BD, et al. A novel panel of alpha-synuclein antibodies reveal distinctive staining profiles in synucleinopathies. PLoS One. 2017;12(9):e0184731.
  • Schmid AW, Fauvet B, Moniatte M, et al. Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies. Mol Cell Proteomics. 2013 Dec;12(12):3543–3558.
  • Lassen LB, Gregersen E, Isager AK, et al. ELISA method to detect alpha-synuclein oligomers in cell and animal models. PLoS One. 2018;13(4):e0196056.
  • Lee HJ, Bae EJ, Jang A, et al. Enzyme-linked immunosorbent assays for alpha-synuclein with species and multimeric state specificities. J Neurosci Methods. 2011 Aug 15;199(2):249–257.
  • Vaikath NN, Majbour NK, Paleologou KE, et al. Generation and characterization of novel conformation-specific monoclonal antibodies for alpha-synuclein pathology. Neurobiol Dis. 2015 Jul;79:81–99.
  • Giuseppe Pugliese FP, Leto G, Amadio L, et al. The diabetic milieu modulates the advanced glycation end product–receptor complex in the mesangium by inducing or upregulating Galectin-3 expression. DIABETES. 2000;49:1249–1257.
  • Liu FT, Hsu DK, Zuberi RI, et al. Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. Biochemistry. 1996 May 14;35(19):6073–6079.
  • Delacour D, Greb C, Koch A, et al. Apical sorting by galectin-3-dependent glycoprotein clustering. Traffic. 2007 Apr;8(4):379–388.
  • Pieter Muntendam SW. inventor GALECTIN-3 Immunoassay. (United States patent US 2017/0370944A1). 2017.